drugset / Trial / NCT05722951
Metformin Efficacy and Safety in Epileptic Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
The goal of this clinical trial is to Evaluating Metformin Efficacy and Safety when Co-administered with Antiepileptic Drugs in Patients with Seizures. The main question it aims to answer is: * Does metformin have beneficial effect on epileptic patients? * How metformin can affect epileptic patient's health? Participants will be divided into 2 groups (control group and treatment group) * Control group will receive standard treatment (levetiracetam \&/or sodium valproate). * Treatment group will receive standard treatment (levetiracetam \&/or sodium valproate) + metformin
Timeline
- Start
- 2022-10-18
- Primary completion
- 2024-06-20
- Completion
- 2024-06-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | — | — |
| Background | Levetiracetam | Other / unclassified | — | — |
| Background | Valproate | Small molecule | — | — |